Did PROTEUS just change Urology??

About this episode

The episode discusses the implications of the PROTEUS trial results for prostate cancer surgery with insights from lead author Dr Mary-Ellen Taplin.

Breaking News podcast just after the long-awaited PROTEUS trial reads out at the ASCO Plenary in Chicago! Plus a simultaneous NEJM paper! Huge day for prostate cancer surgery. Declan and Renu are joined by lead author Dr Mary-Ellen Taplin (Dana Farber Cancer Institute & Harvard University), to tell us about her decades long journey to this huge moment today. PROTEUS is a huge (2,100 men) phase III RCT of men undergoing radical prostatectomy for high-risk prostate cancer, randomised ...

People in this episode

Hosts: Professor Declan Murphy, Dr Renu Eapen

Guest: Dr Mary-Ellen Taplin

Topics covered

• prostate cancer
• surgery
• clinical trials
• medical research
• urology
• healthcare

Keywords

• PROTEUS trial
• prostate cancer
• radical prostatectomy
• clinical trial
• ASCO
• medical research
• Dr Mary-Ellen Taplin

Mentioned in this episode

Organizations: Dana Farber Cancer Institute, Harvard University

Books & works: NEJM

More episodes of GU Cast | Urology Podcast

• Bayer Apex comes to Melbourne! · June 9, 2026 · 26 min
• ARASEC and Lead-in ADT - China focus · May 17, 2026 · 32 min
• Is Copper the new Gold??! Co-PSMA trial in European Urology · April 23, 2026 · 27 min
• EAU Prostate Cancer Guideline Update · April 12, 2026 · 29 min
• Journal club #7 | proPSMA and Penile Fractures(!) · April 6, 2026 · 28 min
• ASPIRE-ing to answer the Triplet question! With Rana McKay and Deepak Kilari · April 2, 2026 · 25 min